EGFR and cancer: It is therefore reasonable to evaluate the effects of pathway inhibitors, such as those targeting EGFR and IGF-IR, which have been shown under 2D conditions to influence the proliferation of cancer cells with distinct molecular profiles, using models that more closely simulate the biological complexity of the tumor microenvironment [27].